Soleno Therapeutics, Inc. (SLNO) Misses Q3 EPS by 37c

Soleno Therapeutics, Inc. (NASDAQ: SLNO) reported Q3 EPS of ($0.95), $0.37 worse than the analyst estimate of ($0.58).

For earnings history and earnings-related data on Soleno Therapeutics, Inc. (SLNO) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Hermès can regain momentum despite China weakness, Jefferies says
• Credo Technology pops 3.5% as Evercore initiates with monster $325 price target